64B16-26.204: Licensure by Endorsement
PURPOSE AND EFFECT: The Board proposes the rule amendment to add new application and to clarify CE requirements.
SUMMARY: A new application will be incorporated into the rule; CE requirements will be clarified.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared. The Board determined the proposed rule will not have an impact on small business.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 456.033, 465.005, 465.0075 FS.
LAW IMPLEMENTED: 456.013(1), 456.033, 465.007, 465.0075, 465.022 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253
THE FULL TEXT OF THE PROPOSED RULE IS:
64B16-26.204 Licensure by Endorsement.
An applicant for licensure by endorsement must be at least 18 years of age and a recipient of a degree from a school or college of pharmacy accredited by an accrediting agency recognized and approved by the United States Office of Education.
(1) All applications for licensure by endorsement shall be made on board approved form DH-MQA 100 effective September 2009, DOH/MQA/PH100 (Rev. 01/2009). The instructions and application form, entitled Florida Pharmacist Licensure by Endorsement Application and Instructions (U.S. and Puerto Rico), which is hereby incorporated by reference, can be obtained from the Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254, or (850)488-0595 to request a form or download the form from the board’s website at http://www.doh.state.fl.us/mqa/pharmacy. The application must and shall be accompanied with a non-refundable endorsement application fee and initial licensure fee as set forth in Rules 64B16-26.1001 and 64B16-26.1002, F.A.C.
(2) The applicant must submit satisfactory proof that one of the following requirements has been met:
(a) Two (2) years of active practice, as defined in Section 465.0075(1)(c), F.S., within the immediately preceding five (5) years. If the applicant meets the requirements of this section, proof of completion of 30 hours of Florida Board of Pharmacy, ACPE, or other state board of pharmacy approved continuing education obtained in the two calendar years immediately preceding application, must also be submitted.
(b) Successful completion of an internship meeting the requirements of Section 465.007(1)(c), F.S., within the immediately preceding two (2) years.
(3) Completion of a Board approved course not less than 2 hours on medication errors that covers the study of root-cause analysis, error reduction and prevention, and patient safety. For applicants who apply within one year following receipt of their pharmacy degree, completed academic course work on medication errors will be accepted by the Board as an educational course under this section, provided such course work is no less than 2 contact hours and that it covers the study of root-cause analysis, error reduction and prevention, and patient safety as evidenced by a letter attesting to subject matter covered from the Dean of the University. The applicant must submit satisfactory proof of completion of the following:
A course of no less than two (2) hours on medication errors covering the subjects set forth in Rule 64B16-26.103, F.A.C. The course shall be completed no earlier than 12 months prior to application.
(4) through (8) No change.
Rulemaking Authority 456.033, 465.005, 465.0075 FS. Law Implemented 456.013(1), 456.033, 465.007, 465.0075, 465.022 FS. History–New 11-8-01, Amended 1-11-05, 2-18-08, 5-26-09,________.